FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095929921> ?p ?o ?g. }

• W3095929921 endingPage "517" @default.
• W3095929921 startingPage "510" @default.
• W3095929921 abstract "Purpose To perform a randomized controlled trial comparing platelet-rich plasma (PRP) with standard corticosteroid (CS) injection in providing pain relief and improved function in patients with rotator cuff tendinopathy and partial-thickness rotator cuff tears (PTRCTs). Methods This double-blind randomized controlled trial enrolled patients with ultrasound-proven or magnetic resonance imaging–proven PTRCTs who received either an ultrasound-guided PRP or CS injection. Patients completed patient-reported outcome assessments at baseline and at 6 weeks, 3 months, and 12 months after injection. The primary outcome was improvement in the visual analog scale (VAS) score for pain. Secondary outcomes included changes in American Shoulder and Elbow Surgeons (ASES) and Western Ontario Rotator Cuff Index (WORC) scores. Treatment failure was defined as subsequent injection, consent to undergo surgery, or operative intervention. Results We followed up 99 patients (47 in the PRP group and 52 in the CS group) until 12 months after injection. There were no differences in baseline patient demographic characteristics including age, sex, or duration of symptoms. Despite randomization, patients in the PRP group had worse baseline VAS (46.0 vs 34.7, P = .01), ASES (53.9 vs 61.8, P = .02), and WORC (42.2 vs 49.5, P = .03) scores. At 3 months after injection, the PRP group had superior improvement in VAS (–13.6 vs 0.4, P = .03), ASES (13.0 vs 2.9, P = .02), and WORC (16.8 vs 5.8, P = .03) scores. There were no differences in patient-reported outcomes at 6 weeks or 12 months. There was no difference in the rate of failure (P = .31) or conversion to surgery (P = .83) between groups. Conclusions Patients with PTRCTs or tendinopathy experienced clinical improvement in pain and patient-reported outcome scores after both ultrasound-guided CS and PRP injections. Patients who received PRP obtained superior improvement in pain and function at short-term follow-up (3 months). There was no sustained benefit of PRP over CS at longer-term follow-up (12 months). Level of Evidence Level I, randomized controlled trial. To perform a randomized controlled trial comparing platelet-rich plasma (PRP) with standard corticosteroid (CS) injection in providing pain relief and improved function in patients with rotator cuff tendinopathy and partial-thickness rotator cuff tears (PTRCTs). This double-blind randomized controlled trial enrolled patients with ultrasound-proven or magnetic resonance imaging–proven PTRCTs who received either an ultrasound-guided PRP or CS injection. Patients completed patient-reported outcome assessments at baseline and at 6 weeks, 3 months, and 12 months after injection. The primary outcome was improvement in the visual analog scale (VAS) score for pain. Secondary outcomes included changes in American Shoulder and Elbow Surgeons (ASES) and Western Ontario Rotator Cuff Index (WORC) scores. Treatment failure was defined as subsequent injection, consent to undergo surgery, or operative intervention. We followed up 99 patients (47 in the PRP group and 52 in the CS group) until 12 months after injection. There were no differences in baseline patient demographic characteristics including age, sex, or duration of symptoms. Despite randomization, patients in the PRP group had worse baseline VAS (46.0 vs 34.7, P = .01), ASES (53.9 vs 61.8, P = .02), and WORC (42.2 vs 49.5, P = .03) scores. At 3 months after injection, the PRP group had superior improvement in VAS (–13.6 vs 0.4, P = .03), ASES (13.0 vs 2.9, P = .02), and WORC (16.8 vs 5.8, P = .03) scores. There were no differences in patient-reported outcomes at 6 weeks or 12 months. There was no difference in the rate of failure (P = .31) or conversion to surgery (P = .83) between groups. Patients with PTRCTs or tendinopathy experienced clinical improvement in pain and patient-reported outcome scores after both ultrasound-guided CS and PRP injections. Patients who received PRP obtained superior improvement in pain and function at short-term follow-up (3 months). There was no sustained benefit of PRP over CS at longer-term follow-up (12 months)." @default.
• W3095929921 created "2020-11-09" @default.
• W3095929921 creator A5009077602 @default.
• W3095929921 creator A5009914492 @default.
• W3095929921 creator A5019631536 @default.
• W3095929921 creator A5021175270 @default.
• W3095929921 creator A5041395749 @default.
• W3095929921 creator A5044171962 @default.
• W3095929921 creator A5088950220 @default.
• W3095929921 date "2021-02-01" @default.
• W3095929921 modified "2023-10-18" @default.
• W3095929921 title "Platelet-Rich Plasma in Patients With Partial-Thickness Rotator Cuff Tears or Tendinopathy Leads to Significantly Improved Short-Term Pain Relief and Function Compared With Corticosteroid Injection: A Double-Blind Randomized Controlled Trial" @default.
• W3095929921 cites W183527674 @default.
• W3095929921 cites W1973064592 @default.
• W3095929921 cites W1975689425 @default.
• W3095929921 cites W1980620587 @default.
• W3095929921 cites W2024439772 @default.
• W3095929921 cites W2044821056 @default.
• W3095929921 cites W2076438700 @default.
• W3095929921 cites W2077797817 @default.
• W3095929921 cites W2098252951 @default.
• W3095929921 cites W2098654980 @default.
• W3095929921 cites W2105391489 @default.
• W3095929921 cites W2113931877 @default.
• W3095929921 cites W2121299060 @default.
• W3095929921 cites W2138108414 @default.
• W3095929921 cites W2148080767 @default.
• W3095929921 cites W2155663618 @default.
• W3095929921 cites W2163350304 @default.
• W3095929921 cites W2164505387 @default.
• W3095929921 cites W2212543853 @default.
• W3095929921 cites W2227867571 @default.
• W3095929921 cites W2321036463 @default.
• W3095929921 cites W2395516203 @default.
• W3095929921 cites W2410527853 @default.
• W3095929921 cites W2463845948 @default.
• W3095929921 cites W2501703094 @default.
• W3095929921 cites W2514598630 @default.
• W3095929921 cites W2563112167 @default.
• W3095929921 cites W2616795795 @default.
• W3095929921 cites W2750499448 @default.
• W3095929921 cites W2896243120 @default.
• W3095929921 cites W2901882952 @default.
• W3095929921 cites W2911827485 @default.
• W3095929921 cites W2938914809 @default.
• W3095929921 cites W2949044218 @default.
• W3095929921 cites W2979393725 @default.
• W3095929921 cites W2980221088 @default.
• W3095929921 cites W4232865669 @default.
• W3095929921 cites W4297832561 @default.
• W3095929921 doi "https://doi.org/10.1016/j.arthro.2020.10.037" @default.
• W3095929921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33745940" @default.
• W3095929921 hasPublicationYear "2021" @default.
• W3095929921 type Work @default.
• W3095929921 sameAs 3095929921 @default.
• W3095929921 citedByCount "46" @default.
• W3095929921 countsByYear W30959299212021 @default.
• W3095929921 countsByYear W30959299212022 @default.
• W3095929921 countsByYear W30959299212023 @default.
• W3095929921 crossrefType "journal-article" @default.
• W3095929921 hasAuthorship W3095929921A5009077602 @default.
• W3095929921 hasAuthorship W3095929921A5009914492 @default.
• W3095929921 hasAuthorship W3095929921A5019631536 @default.
• W3095929921 hasAuthorship W3095929921A5021175270 @default.
• W3095929921 hasAuthorship W3095929921A5041395749 @default.
• W3095929921 hasAuthorship W3095929921A5044171962 @default.
• W3095929921 hasAuthorship W3095929921A5088950220 @default.
• W3095929921 hasConcept C126322002 @default.
• W3095929921 hasConcept C126838900 @default.
• W3095929921 hasConcept C141071460 @default.
• W3095929921 hasConcept C14184104 @default.
• W3095929921 hasConcept C143409427 @default.
• W3095929921 hasConcept C168563851 @default.
• W3095929921 hasConcept C204243189 @default.
• W3095929921 hasConcept C2776030733 @default.
• W3095929921 hasConcept C2776511800 @default.
• W3095929921 hasConcept C2776804153 @default.
• W3095929921 hasConcept C2778275304 @default.
• W3095929921 hasConcept C2778911562 @default.
• W3095929921 hasConcept C2780076745 @default.
• W3095929921 hasConcept C2780105995 @default.
• W3095929921 hasConcept C2781184374 @default.
• W3095929921 hasConcept C2909889181 @default.
• W3095929921 hasConcept C71924100 @default.
• W3095929921 hasConcept C89560881 @default.
• W3095929921 hasConceptScore W3095929921C126322002 @default.
• W3095929921 hasConceptScore W3095929921C126838900 @default.
• W3095929921 hasConceptScore W3095929921C141071460 @default.
• W3095929921 hasConceptScore W3095929921C14184104 @default.
• W3095929921 hasConceptScore W3095929921C143409427 @default.
• W3095929921 hasConceptScore W3095929921C168563851 @default.
• W3095929921 hasConceptScore W3095929921C204243189 @default.
• W3095929921 hasConceptScore W3095929921C2776030733 @default.
• W3095929921 hasConceptScore W3095929921C2776511800 @default.
• W3095929921 hasConceptScore W3095929921C2776804153 @default.
• W3095929921 hasConceptScore W3095929921C2778275304 @default.
• W3095929921 hasConceptScore W3095929921C2778911562 @default.
• W3095929921 hasConceptScore W3095929921C2780076745 @default.

• next